Tuesday, April 25, 2017 7:14:59 PM
----
Frederic Ors Acquires 20,000 Shares of ImmunoVaccine Inc. (IMV) Stock
Posted by Casey Walker on Apr 25th, 2017 //
ImmunoVaccine Inc. (TSE:IMV) Director Frederic Ors bought 20,000 shares of the business’s stock in a transaction dated Thursday, April 20th. The stock was purchased at an average price of C$1.20 per share, for a total transaction of C$24,000.00.
Frederic Ors also recently made the following trade(s):
On Thursday, February 9th, Frederic Ors bought 22,300 shares of ImmunoVaccine stock. The stock was purchased at an average price of C$0.99 per share, for a total transaction of C$22,077.00.
On Tuesday, February 7th, Frederic Ors bought 5,000 shares of ImmunoVaccine stock. The stock was purchased at an average price of C$1.07 per share, for a total transaction of C$5,350.00.
Shares of ImmunoVaccine Inc. (TSE:IMV) traded up 10.00% on Tuesday, hitting $1.32. 364,270 shares of the stock traded hands. The firm has a 50 day moving average price of $1.17 and a 200 day moving average price of $0.91. The firm’s market cap is $157.02 million. ImmunoVaccine Inc. has a 52-week low of $0.51 and a 52-week high of $1.40.
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
